fda glp-1 warning letters september 2025 takes aim at telehealth companies for promoting unofficial weight loss drug dupes FDA Issues 30 Warning Letters

Additionally, these agents demonstrate remarkable cardiovascular risk reduction in high-risk type 2 diabetes patients

A 2025 study reported evidence of telomere length stabilization or modest lengthening, raising the possibility that metabolic therapies may influence pathways related to genomic stability and replicative lifespan [16]

The risk of a missed interaction or a subtle disease change going unnoticed increases with medication complexity

This process is typically quick (often completed within 24-48 hours of your consultation)

MRI: Magnetic resonance imaging

If you're taking insulin or sulfonylureas (glipizide, glimepiride, glyburide, and similar), adding a GLP-1 medication increases your risk of hypoglycemia